Table of Content - Ranitidine Market

Ranitidine is a histamine type 2 (H2) receptor blocker drug available by prescription as well as over-the-counter (OTC). Ranitidine is used in treatment of intestinal & stomach ulcers, gastroesophageal reflux disease (GERD), and erosive esophagitis, and Zollinger-Ellison syndrome. Stomach ulcer or peptide ulcer causes open sores in the inner lining of stomach and upper portion of small intestine. Ranitidine helps to reduce excessive acid production in patient’s stomach. Increasing prevalence of risk factors to cause peptide ulcers in patients such as use of pain relievers, use of certain medications (steroids, low-dose aspirin, combination of selective serotonin reuptake inhibitors (SSRIs) with pain relievers), smoking, excessive alcohol consumption, untreated stress and easting of spicy foods; greatly increases the chance of developing ulcers.

Market Dynamics

Ranitidine market is expected to witness growth during the forecast period, owing to growing prevalence of gastroesophageal reflux disease (GERD) and stomach and intestinal ulcers, worldwide. For instance, a review study published in the Gut Journal in June 2014, estimated the range of GERD prevalence in global population, in 2014. This study reported GERD prevalence as 18%- 28% in North America, 9%-26% in Europe, 3%-8% in East Asia, 9%-33% in Middle East, 12% in Australia, and 23% in Latin America. According to this statistics, North America and Middle East are at higher risk to develop GERD disease.

Furthermore, higher efficacy and tolerability of ranitidine in suppression of stomach & intestinal ulcers is increasing the adoption of ranitidine-based medication in the market.

Key features of the study

This report provides in-depth analysis of ranitidine market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2026 - 2033), considering 2025, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches and approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global ranitidine market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies and future plans
Key companies covered as a part of this study include GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Strides Pharma Science Limited (Strides Shasun), Tocris Bioscience (R&D Systems), Merck KGaA, and Sun Pharmaceutical Industries Limited among others.
Insights from this report would allow marketers and management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global ranitidine market report caters to various stakeholders in this industry including investors, suppliers, ranitidine-based product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the ranitidine market.

Market Segmentation

By Strength (Revenue, USD Mn, 2021-2033)
- 75 mg
- 150 mg
- 300 mg
By Form (Revenue, USD Mn, 2021-2033)
- Tablets
- Syrup
- Injection
By Route of Administration (Revenue, USD Mn, 2021-2033)
- Oral
- Intravenous
By Application (Revenue, USD Mn, 2021-2033)
- Intestinal & Stomach Ulcers
- Gastroesophageal Reflux Disease (GERD)
- Esophagitis
- Zollinger-Ellison Syndrome
- Others
By Distribution Channel (Revenue, USD Mn, 2021-2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Ranitidine Market, By Region: (Revenue, USD Mn, 2021-2033)
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - South Africa
  - Central Africa
  - North Africa
Key Players
- GlaxoSmithKline plc
- Boehringer Ingelheim GmbH
- Strides Pharma Science Limited (StridesShasun)
- Tocris Bioscience (R & D Systems)
- Merck KGaA
- Sun Pharmaceutical Industries Limited

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Strength
  - Market Snapshot, By Form
  - Market Snapshot, By Route of Administration
  - Market Snapshot, By Application
  - Market Snapshot, By Distribution Channel
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Product Approval
- Collaboration/Merge/Acquisition
- Regulatory Landscape
- PEST Analysis
- Porter’s Five Forces Analysis
- Epidemiology
- Robust Pipeline Analysis
Global Ranitidine Market, By Strength, 2021 – 2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022– 2033
  - Segment Trends
- 75 mg
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
- 150 mg
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
- 300 mg
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
Global Ranitidine Market, By Form, 2021 – 2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Tablets
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
- Syrup
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
- Injection
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
Global Ranitidine Market, By Route of Administration, 2021 – 2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Oral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
- Intravenous
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
Global Ranitidine Market, By Application, 2021 – 2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Intestinal & Stomach Ulcers
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
- Gastroesophageal Reflux Disease (GERD)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
- Esophagitis
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
- Zollinger-Ellison Syndrome
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
Global Ranitidine Market, By Distribution Channel, 2021 – 2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
Global Ranitidine Market, By Region, 2021 – 2033, (USD Mn)
- Introduction
  - Market Share Analysis, By Region, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, For Regions, 2022–2033
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Strength, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Form, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Mn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Strength, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Form, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Mn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Strength, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Form, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Mn)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Strength, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Form, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Mn)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Strength, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Form, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Mn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Strength, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Form, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Mn)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Company Profile
  - GlaxoSmithKline plc
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Boehringer Ingelheim GmbH
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Strides Pharma Science Limited (StridesShasun)
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Tocris Bioscience (R & D Systems)
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Merck KGaA
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Sun Pharmaceutical Industries Limited
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
- Analyst Views
Section
- References
- Research Methodology
- About Us

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now

Credibility and Certifications

860519526

9001:2015

27001:2022

Need a Custom Report?

EXISTING CLIENTELE